Related Experiment Video
Updated: Mar 22, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
Published on: December 2, 2014
NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?
Cristiane A Villela-Nogueira1, Nathalie C Leite2, Claudia R L Cardoso3
1Department of Internal Medicine, Medical School and University Hospital Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rua Croton 72, Rio de Janeiro 22750-240, Brazil. crisvillelanog@gmail.com.
Non-alcoholic fatty liver disease (NAFLD) is linked to increased aortic stiffness, a cardiovascular risk marker. This review explores the connection between NAFLD and arterial stiffness, highlighting shared pathways.
Area of Science:
- Hepatology
- Cardiology
- Vascular Biology
Background:
- Non-alcoholic fatty liver disease (NAFLD) is the primary cause of chronic liver disease globally.
- NAFLD-related liver inflammation and fibrosis escalate disease progression and mortality.
- Emerging evidence links NAFLD to atherosclerotic vascular disease, independent of traditional risk factors.
Purpose of the Study:
- To review existing literature on the association between NAFLD and aortic stiffness.
- To elucidate the interplay between NAFLD and aortic stiffness.
- To identify potential common pathophysiological mechanisms linking these conditions.
Main Methods:
- Systematic literature search for studies investigating NAFLD and aortic stiffness.
- Analysis of data on carotid-femoral pulse wave velocity (cf-PWV) as a measure of aortic stiffness.
- Review of studies examining cardiovascular risk factors in NAFLD patients.
Main Results:
- Published studies consistently report a strong association between NAFLD and increased aortic stiffness.
- Increased aortic stiffness, measured by cf-PWV, is a predictor of cardiovascular events.
- NAFLD may contribute to atherosclerosis through shared inflammatory and metabolic pathways.
Conclusions:
- NAFLD is significantly associated with increased aortic stiffness.
- Arterial stiffness may serve as a marker for cardiovascular risk in NAFLD patients.
- Further research into shared pathophysiological mechanisms is warranted to inform clinical management.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease I: Introduction
Peripheral Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Heart Failure II: Pathophysiology

